| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2025 ( Subtotal = $621,064 ) |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH121617 | Mobile Measures of Threat Sensitivity for Cross-sectional and Longitudinal Assessment | 000 | 5 | NIH | 11/7/2024 | $649,051 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K01MH129828 | Multimodal characterization of affective visual processing in the early aftermath of trauma | 000 | 3 | NIH | 11/14/2024 | $179,707 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R21MH138861 | Observing brain lactate dynamics during a working memory task in first episode and chronic schizophrenia | 000 | 1 | NIH | 11/15/2024 | $246,000 |
| 2025 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23MH132900 | Shared and differential vulnerabilities of stress and reward processing in psychosis-risk syndromes or early-stage depression | 000 | 2 | NIH | 11/4/2024 | $178,416 |
| 2025 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | P50MH115846 | Laboratory for Early Psychosis Research (LEAP) | 000 | 6 | NIH | 11/20/2024 | $0 |
| 2025 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH116969 | Predicting the onset of depression in at-risk adolescents from endophenotype profiles | 000 | 5 | NIH | 10/23/2024 | $0 |
| 2025 | 2023 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23MH121781 | Energy Metabolism Markers of Cognitive Function in Early Psychosis and Risk | 000 | 5 | NIH | 11/21/2024 | $0 |
| 2025 | 2023 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | UG3DA058544 | Antibody-based therapy for fentanyl-related opioid use disorder | 000 | 1 | NIH | 10/17/2024 | $0 |
| 2025 | 2022 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R61MH121640 | Individually targeted neuromodulation for contamination-based OCD | 000 | 2 | NIH | 10/22/2024 | -$632,110 |
| 2025 | 2022 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R21MH125076 | Identification of Trauma-related Features in EHR Data for Patients with Psychosis and Mood Disorders | 000 | 2 | NIH | 10/22/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $31,969,506 ) (Continued on the next page) |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH126000 | Empirical validation of a cerebellar-cortical hallucination circuit | 000 | 3 | NIH | 10/31/2023 | $604,336 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH119227 | Multimodal Approaches to Neurobiology of Traumatic Dissociation | 000 | 5 | NIH | 1/10/2024 | $685,214 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH121617 | Mobile Measures of Threat Sensitivity for Cross-sectional and Longitudinal Assessment | 000 | 4 | NIH | 12/1/2023 | $699,731 |
| 2024 | 2024 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K01MH129828 | Multimodal characterization of affective visual processing in the early aftermath of trauma | 000 | 2 | NIH | 10/18/2023 | $179,707 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23MH126193 | Interpretation Bias as a Mechanism of Treatment Response in OCD | 000 | 3 | NIH | 12/15/2023 | $181,688 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH129374 | Parent interpretation bias as a key mechanism of intergenerational transmission of anxiety | 000 | 2 | NIH | 2/15/2024 | $664,987 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH135093 | Molecular Mechanisms of Aging in Schizophrenia: Implications of Bioenergetic Metabolism and Redox Biology | 000 | 1 | NIH | 2/1/2024 | $761,943 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH116969 | Predicting the onset of depression in at-risk adolescents from endophenotype profiles | 001 | 5 | NIH | 8/15/2024 | $54,426 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH129374 | Parent interpretation bias as a key mechanism of intergenerational transmission of anxiety | 002 | 2 | NIH | 8/14/2024 | $73,887 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH129374 | Parent interpretation bias as a key mechanism of intergenerational transmission of anxiety | 001 | 2 | NIH | 4/30/2024 | $111,618 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R21MH136479 | Utilizing circRNA transcriptomics for functional characterization of psychiatric GWAS | 000 | 1 | NIH | 4/5/2024 | $246,000 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH135093 | Molecular Mechanisms of Aging in Schizophrenia: Implications of Bioenergetic Metabolism and Redox Biology | 001 | 1 | NIH | 5/6/2024 | $82,879 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01DA058315 | Impact of prescription stimulants on the drug overdose epidemic | 002 | 2 | NIH | 4/25/2024 | $73,854 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01DA058315 | Impact of prescription stimulants on the drug overdose epidemic | 000 | 2 | NIH | 3/21/2024 | $664,686 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01DA058315 | Impact of prescription stimulants on the drug overdose epidemic | 001 | 2 | NIH | 4/11/2024 | $0 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH116969 | Predicting the onset of depression in at-risk adolescents from endophenotype profiles | 000 | 5 | NIH | 12/4/2023 | $489,856 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH133268 | Next steps for PTSD genomics: from loci to function | 000 | 1 | NIH | 5/17/2024 | $843,254 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH133268 | Next steps for PTSD genomics: from loci to function | 001 | 1 | NIH | 5/21/2024 | $0 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01DA054113 | The Role of Behavior Therapy Combined with Buprenorphine for the Treatment of Opioid Use Disorder | 000 | 3 | NIH | 4/23/2024 | $350,550 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23DA050808 | Improving Treatment Engagement in Individuals with Co-occurring Substance Use and Psychosis: A Telemedicine Family-Based Approach | 000 | 5 | NIH | 5/29/2024 | $189,232 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R00GM141449 | Unraveling the neural basis of female aggression and dementia-related aggression: a systems biology approach. | 000 | 5 | NIH | 5/15/2024 | $249,000 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R00GM141449 | Unraveling the neural basis of female aggression and dementia-related aggression: a systems biology approach. | 001 | 5 | NIH | 6/6/2024 | $104,973 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH134885 | 3/5- Biomarkers to Enhance Early Schizophrenia Treatment (BEEST) | 000 | 1 | NIH | 9/5/2024 | $389,921 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23MH132900 | Shared and differential vulnerabilities of stress and reward processing in psychosis-risk syndromes or early-stage depression | 000 | 1 | NIH | 11/16/2023 | $178,416 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01AA030585 | Insula-amygdala circuits in alcohol abuse | 000 | 2 | NIH | 7/16/2024 | $516,261 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01DA017846 | Early Stress and the Neurobiology of Susceptibility and Resilience to Substance Use Disorders | 000 | 15 | NIH | 6/26/2024 | $733,785 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH108665 | Cell Type Specific Genomic and Functional Dissection of Fear-Off Amygdala Pathways | 000 | 9 | NIH | 6/17/2024 | $776,261 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH108665 | Cell Type Specific Genomic and Functional Dissection of Fear-Off Amygdala Pathways | 001 | 9 | NIH | 6/18/2024 | $52,464 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | T32DA015036 | Training in Drug Abuse and Brain Imaging | 000 | 23 | NIH | 5/24/2024 | $296,588 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | P50MH119467 | Novel Treatment Targets For Affective Disorders Through Cross-Species Investigation of Approach/Avoidance Decision Making | 001 | 5 | NIH | 8/15/2024 | $315,188 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23MH122668 | Neural Correlates of Stress and Perceived Control in Adolescent Depression | 000 | 5 | NIH | 5/13/2024 | $181,116 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | P50MH119467 | Novel Treatment Targets For Affective Disorders Through Cross-Species Investigation of Approach/Avoidance Decision Making | 000 | 5 | NIH | 3/19/2024 | $2,836,693 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | P50MH115846 | Laboratory for Early Psychosis Research (LEAP) | 004 | 6 | NIH | 8/29/2024 | $2,037,513 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH126000 | Empirical validation of a cerebellar-cortical hallucination circuit | 001 | 3 | NIH | 6/27/2024 | $67,148 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23DA050780 | Increasing Women's Engagement in Medication Treatment for Opioid Use Disorder through Digital Intervention | 000 | 5 | NIH | 6/26/2024 | $187,540 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K00HD111352 | Transgenerational Impact of Childhood Maltreatment on Structural/Functional Properties of Visual Cortex | 000 | 5 | NIH | 6/26/2024 | $91,678 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K99MH133869 | Amygdala Circuit Mechanisms for Stress-escalated Aggression | 000 | 2 | NIH | 7/3/2024 | $127,710 |
| 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23MH137459 | A Multilevel Characterization of Sensory Cortical Disinhibition in Post-Traumatic Intrusions | 000 | 1 | NIH | 7/10/2024 | $179,002 |
|